ID tissue individual Age Clinical status Sex Immunosupression Histopathology Donor type Scr (mg/dL) Days post transplant Patient_ID GSM26805 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C1 GSM26806 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C2 GSM26807 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C3 GSM26808 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C4 GSM26809 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C5 GSM26810 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C6 GSM26811 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C7 GSM26812 peripheral blood lymphocyte normal donor unknown control healthy blood donor unknown none none NA unknown NA C8 GSM26813 peripheral blood lymphocyte acute rejection 28 PBL sample from transplant patient with kidney undergoing acute rejection Male FK/MMF/P Banff IIA LD 5.9 1467 AR2 GSM26814 peripheral blood lymphocyte acute rejection 18 PBL sample from transplant patient with kidney undergoing acute rejection Male CsA/MMF/P Banff IA CAD 2.2 119 AR3 GSM26815 peripheral blood lymphocyte acute rejection 28 PBL sample from transplant patient with kidney undergoing acute rejection Female FK/MMF/P Banff IA CAD 1.5 366 AR4 GSM26816 peripheral blood lymphocyte acute rejection 26 PBL sample from transplant patient with kidney undergoing acute rejection Female CsA/MMF/P Banff borderline CAD 2.0 278 AR5 GSM26817 peripheral blood lymphocyte acute rejection 55 PBL sample from transplant patient with kidney undergoing acute rejection Male SRL/MMF/P Banff borderline CAD 2.9 68 AR6 GSM26818 peripheral blood lymphocyte acute rejection 35 PBL sample from transplant patient with kidney undergoing acute rejection Male SRL/MMF/P Banff IA CAD 2.0 184 AR7 GSM26819 peripheral blood lymphocyte well-functioning transplant 38 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P none CAD 1.4 461 TX1 GSM26820 peripheral blood lymphocyte well-functioning transplant 57 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Female FK/MMF/P none LD 1.3 42 TX2 GSM26821 peripheral blood lymphocyte well-functioning transplant 65 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P none CAD 1.5 213 TX3 GSM26822 peripheral blood lymphocyte well-functioning transplant 65 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Female FK/MMF/P none CAD 0.8 246 TX4 GSM26823 peripheral blood lymphocyte well-functioning transplant 36 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Female CsA/MMF/P none CAD 1.1 1278 TX5 GSM26824 peripheral blood lymphocyte well-functioning transplant 68 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P none CAD 1.7 376 TX6 GSM26825 peripheral blood lymphocyte well-functioning transplant 39 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Male SRL/MMF/P none CAD 0.9 36 TX7 GSM26826 peripheral blood lymphocyte well-functioning transplant 61 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Female CsA/MMF/P none CAD 0.9 1491 TX8 GSM26827 peripheral blood lymphocyte well-functioning transplant 46 PBL sample from patient with well-functioning transplant with no clinical evidence of rejection Male SRL/MMF/P none LD 1.2 81 TX9 GSM26828 peripheral blood lymphocyte renal dysfunction w/o rejection 55 PBL sample from transplant patient with renal dysfunction without rejection Male CsA/MMF/P CNI toxicity LD 1.7 456 NR1 GSM26829 peripheral blood lymphocyte renal dysfunction w/o rejection 38 PBL sample from transplant patient with renal dysfunction without rejection Male FK/MMF/P CNI toxicity LD 2.3 155 NR2 GSM26830 peripheral blood lymphocyte renal dysfunction w/o rejection 61 PBL sample from transplant patient with renal dysfunction without rejection Male SRL/MMF/P ATN LD 5.2 11 NR3 GSM26831 peripheral blood lymphocyte renal dysfunction w/o rejection 43 PBL sample from transplant patient with renal dysfunction without rejection Male CsA/MMF/P CNI toxicity CAD 3.8 262 NR4 GSM26832 peripheral blood lymphocyte renal dysfunction w/o rejection 35 PBL sample from transplant patient with renal dysfunction without rejection Male CsA/MMF/P ATN CAD 6.3 16 NR5 GSM26833 peripheral blood lymphocyte renal dysfunction w/o rejection 44 PBL sample from transplant patient with renal dysfunction without rejection Male SRL/MMF/P ATN CAD 6.3 40 NR6 GSM26834 peripheral blood lymphocyte renal dysfunction w/o rejection 22 PBL sample from transplant patient with renal dysfunction without rejection Female FK/MMF/P FSGS LD 3.3 78 NR7 GSM26835 peripheral blood lymphocyte renal dysfunction w/o rejection 58 PBL sample from transplant patient with renal dysfunction without rejection Male CsA/MMF/P ATN CAD 5.0 47 NR8 GSM26836 kidney normal donor 38 control healthy donor kidney Female none none LD 0.8 0 C1 GSM26837 kidney normal donor 42 control healthy donor kidney Male none none LD 0.9 0 C2 GSM26838 kidney normal donor 35 control healthy donor kidney Female none none LD 0.6 0 C3 GSM26839 kidney normal donor 39 control healthy donor kidney Female none none LD 0.9 0 C4 GSM26840 kidney normal donor 39 control healthy donor kidney Male none none LD 1.2 0 C5 GSM26841 kidney normal donor 44 control healthy donor kidney Male none none LD 0.8 0 C6 GSM26842 kidney normal donor 36 control healthy donor kidney Male none none LD 1.2 0 C7 GSM26843 kidney normal donor 35 control healthy donor kidney Female none none LD 0.8 0 C8 GSM26844 kidney normal donor 50 control healthy donor kidney Female none none LD 0.6 0 C9 GSM26845 kidney acute rejection 42 sample from transplant patient with kidney undergoing acute rejection Male CsA/MMF/P Banff IIA CAD 12.0 285 AR1 GSM26846 kidney acute rejection 28 sample from transplant patient with kidney undergoing acute rejection Male FK/MMF/P Banff IIA LD 5.9 1467 AR2 GSM26847 kidney acute rejection 18 sample from transplant patient with kidney undergoing acute rejection Male CsA/MMF/P Banff IA CAD 2.2 119 AR3 GSM26848 kidney acute rejection 28 sample from transplant patient with kidney undergoing acute rejection Female FK/MMF/P Banff IA CAD 1.5 366 AR4 GSM26849 kidney acute rejection 26 sample from transplant patient with kidney undergoing acute rejection Female CsA/MMF/P Banff borderline CAD 2.0 278 AR5 GSM26850 kidney acute rejection 55 sample from transplant patient with kidney undergoing acute rejection Male SRL/MMF/P Banff borderline CAD 2.9 68 AR6 GSM26851 kidney acute rejection 35 sample from transplant patient with kidney undergoing acute rejection Male SRL/MMF/P Banff IA CAD 2.0 184 AR7 GSM26852 kidney well-functioning transplant 21 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal CAD 1.5 674 TX1 GSM26853 kidney well-functioning transplant 51 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal CAD 1.5 932 TX2 GSM26854 kidney well-functioning transplant 56 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal LD 1.3 911 TX3 GSM26855 kidney well-functioning transplant 52 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal CAD 1.2 902 TX4 GSM26856 kidney well-functioning transplant 31 sample from well-functioning transplant with no clinical evidence of rejection Female CsA/MMF/P Normal LD 1.1 651 TX5 GSM26857 kidney well-functioning transplant 53 sample from well-functioning transplant with no clinical evidence of rejection Female CsA/MMF/P Normal LD 1.1 689 TX6 GSM26858 kidney well-functioning transplant 32 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal LD 1.6 776 TX7 GSM26859 kidney well-functioning transplant 46 sample from well-functioning transplant with no clinical evidence of rejection Female CsA/MMF/P Normal CAD 1.2 713 TX8 GSM26860 kidney well-functioning transplant 61 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal CAD 0.9 733 TX9 GSM26861 kidney well-functioning transplant 44 sample from well-functioning transplant with no clinical evidence of rejection Male CsA/MMF/P Normal LD 1.8 718 TX10 GSM26862 kidney renal dysfunction w/o rejection 55 sample from transplant with renal dysfunction without rejection Male CsA/MMF/P CNI toxicity LD 1.7 456 NR1 GSM26863 kidney renal dysfunction w/o rejection 38 sample from transplant with renal dysfunction without rejection Male FK/MMF/P CNI toxicity LD 2.3 155 NR2 GSM26864 kidney renal dysfunction w/o rejection 61 sample from transplant with renal dysfunction without rejection Male SRL/MMF/P ATN LD 5.2 11 NR3 GSM26865 kidney renal dysfunction w/o rejection 35 sample from transplant with renal dysfunction without rejection Male CsA/MMF/P ATN CAD 6.3 16 NR5 GSM26866 kidney renal dysfunction w/o rejection 22 sample from transplant with renal dysfunction without rejection Female FK/MMF/P FSGS LD 3.3 78 NR8